TESI SIMONA MANDINI - Università degli Studi di Ferrara

30. Malagoni AM, Felisatti M, Mandini S, Mascoli F, Manfredini R, Basaglia N, Zamboni P,
Manfredini F. Resting muscle oxygen consumption by near-infrared spectroscopy in peripheral
arterial disease: a parameter to be considered in a clinical setting Angiology 2010 in press.
31. Homma S, Eda H, Ogasawara S, Kagaya A: Near-infrared estimation of O2 supply and
consumption in forearm muscles working at varying intensity. J Appl Physiol 80:1279-1284,
1996.
32. Wolf U, Wolf M, Choi JH, et al: Localized irregularities in hemoglobin flow and oxygenation in
calf muscle in patients with peripheral vascular disease detected with near-infrared
spectrophotometry. J Vasc Surg 37:1017-1026, 2003.
33. Porter JM, Cutler BS, Lee BY, et al: Pentoxifylline efficacy in the treatment of intermittent
claudication: Multicenter controlled double-blind trial with objective assessment of chronic
occlusive arterial disease patients. Am Heart J 104:66-72, 1982.
34. Reich T, Gillings D. Effects of pentoxifylline on severe intermittent claudication. Angiology
38:651-656, 1987.
35. DeSanctis MT, Cesarone MR, Belcaro G, et al. Treatment of long-distance intermittent
claudication with pentoxifylline; A 12-month, randomized trial. Angiology 53 (suppl):S13-S17,
2002.
36. Dawson DL, Cutler BS, Meissner MH, et al. Cilostazol has beneficial effects in treatment of
intermittent claudication: Results from a multicenter, randomized, prospective, double-blind
trial. Circ J 98:678-686, 1998.
37. Money SR, Herd JA, Isaacsohn JL, et al. Effect of cilostazol on walking distances in patients
with intermittent claudication caused by peripheral vascular disease. J Vasc Surg 27:267-275,
1998.
38. Erb W. Über das “intermittierende Hinken” und andere nervose Storungen in Folge von
Gefäβerkrankungen. Dtsch Z Nervenheilkunde 1898; 13 :1-76.
35